engleski

DISEASE ACTIVITY AND TREATMENT PATTERNS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CROATIA

Access to biologic treatment differ in EU countries and is influenced by different factors. In CEE countries 1%–5% of all RA patients are treated with biological therapy. Factors influencing prescriptions of bio- logics in CEE are mostly macroeconomic conditions and restrictive treatment guidelines but also shortage of specialist prescribers, administrative hurdless and availability of care. [1]. There are published data on access to biologic treatment in Central and Eastern EU countries but there currently is no data in Croatia. Objectives: The aim of this study was to assess and compare patient care and access to biologic therapy for rheu- matoid arthritis (RA) treated in secondary and tertiary institutions in Croatia. Methods: Non-interventional, multicenter study with retrospective chart review to collect demographics and clinical characteristics from patient’s history and a cross-sectional study on date of visit to the rheumatologist with evaluation of DAS28 score and therapeutic interventions taken at this cross-sectional visit. Study was con- ducted in 398 RA patients from Balkan region and this subanalysis is showing results on 130 RA patients from 8 sites in Croatia.

Rheumatoid arthritis, Croatia

nije evidentirano